PAM
LCTX icon

Panagora Asset Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Panagora Asset Management’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-53,136
Closed -$43K – 2610
2020
Q1 		$43K Sell
53,136
-30,308
-36% -$30.2K ﹤0.01% 1924
2019
Q4 		$69K Sell
83,444
-184,844
-69% -$154K ﹤0.01% 1871
2019
Q3 		$262K Sell
268,288
-66,626
-20% -$69K ﹤0.01% 1534
2019
Q2 		$368K Buy
+334,914
New +$386K ﹤0.01% 1549
2017
Q3 		– Sell
-3,695
Closed -$10K – 2416
2017
Q2 		$10K Buy
+3,695
New +$10.3K ﹤0.01% 2405
2015
Q2 		– Sell
-21,824
Closed -$88K – 2450
2015
Q1 		$88K Buy
+21,824
New +$75.5K ﹤0.01% 1969

Other funds holding LCTX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return